Piper Jaffray Raises price Target on Impinj (PI) to $30 Following June Quarter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Impinj (PI) Adds to Strong Post-Earnings Gains
September 2, 2016 11:56 AM EDTImpinj (NASDAQ: PI) adds to yesterday's strong gains following earnings. Shares are up another 13.7% today on volume that is running 6x the norm. Yesterday the stock was up 21%.
... MoreNeedham & Company Raises Price Target as Impinj (PI) Reports Solid 2Q Report
September 1, 2016 8:23 AM EDTNeedham & Company reiterated a Buy rating on Impinj Inc (NASDAQ: PI), and raised the price target to $28.00 (from $24.00), following the company's 2Q earnings report. PA reported revenues of $26.0M, above the consensus estimate of $25.3M. Non-GAAP EPS totaled $0.06, solidly above consensus' $0.02 estimate.
Analyst... More
Impinj (PI): Raising PT After A Beat And Raise Quarter - RBC
September 1, 2016 6:21 AM EDTRBC Capital analyst, Mitch Steves, maintained his Outperform rating on shares of Impinj Inc (NASDAQ: Pi) and raised the price target to $30.00 (from $25.00) after Impinj reported a beat and raise for its first earnings call. While the software piece of the business is new,... More
After-Hours Stock Movers 08/31: (CYNA) (OXM) (OLLI) Higher; (CRM) (SCVL) (FIVE) Lower (more...)
August 31, 2016 5:46 PM EDTAfter-Hours Movers
Cynapsus Therapeutics Inc. (NASDAQ: CYNA) 119% HIGHER; Sunovion Pharmaceuticals Inc. and Cynapsus Therapeutics Inc. (NASDAQ: CYNA) announced that the companies have signed a definitive agreement under which Sunovion will acquire Cynapsus for US$40.50 per share in cash. The transaction has received unanimous approval by the Board of Directors of both companies and values Cynapsus at approximately US$624 million (or approximately CAN$820 million). The acquisition will be funded with cash on hand. The transaction is expected to close in the fourth quarter of 2016... More
Impinj (PI) Tops Q2 EPS by 4c; Offers Q3 Outlook
August 31, 2016 4:04 PM EDTImpinj (NASDAQ: PI) reported Q2 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the quarter came in at $26 million versus the consensus estimate of $25.31 million.
GUIDANCE:
Impinj sees Q3 2016 EPS of $0.01-$0.09, versus the consensus of $0.04. Impinj sees Q3... More



